Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Down Syndrome × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 20 Triple Negative Breast Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 2 Inflammatory Breast Neoplasms 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Hodgkin Disease 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Cytarabine 5 pegaspargase 3 merphos 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 azathiopurine 3 auricularum 3 Vincristine 3 Thioguanine 3 Methotrexate 3 Mercaptopurine 3 Dexamethasone 3 Calcium Dobesilate 3 Asparaginase 3 blinatumomab 2 asparaginase erwinia chrysanthemi recombinant 2 N,N-dicyclohexyl-isoborneol-10-sulfonamide 2 Leucovorin 2 Etoposide 2 Doxorubicin 2 Daunorubicin 2 Cyclophosphamide 2 prednylidene 1 hydrocortisone hemisuccinate 1 deltacortene 1 calaspargase pegol 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy, Conformal 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡